Vectors Research Management’s iShares US Medical Devices ETF IHI Stock Holding History

Vectors Research Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$640K	Sell	12,948 -502	-4%	-$25.5K	0.17%	95
2026 Q1	$718K	Sell	13,450 -6,316	-32%	-$371K	0.21%	86
2025 Q4	$1.23M	Sell	19,766 -846	-4%	-$52.2K	0.37%	68
2025 Q3	$1.24M	Buy	20,612 +1,487	+8%	+$91K	0.39%	68
2025 Q2	$1.2M	Buy	+19,125	New	+$1.15M	0.41%	63
2022 Q3	–	Sell	-1,454	Closed	-$73K	–	292
2022 Q2	$73K	Sell	1,454 -102	-7%	-$5.56K	0.02%	193
2022 Q1	$95K	Hold	1,556	–	–	0.02%	182
2021 Q4	$102K	Buy	1,556 +602	+63%	+$38.5K	0.02%	205
2021 Q3	$60K	Hold	954	–	–	0.01%	223
2021 Q2	$57K	Sell	954 -174	-15%	-$10.1K	0.01%	227
2021 Q1	$62K	Hold	1,128	–	–	0.02%	207
2020 Q4	$62K	Hold	1,128	–	–	0.02%	189
2020 Q3	$56K	Buy	+1,128	New	+$54.6K	0.02%	173

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Vectors Research Management's IHI Position: Q2 2026 in Review

Vectors Research Management reduced its iShares US Medical Devices ETF (IHI) stake by 3.7% in Q2 2026, selling an estimated $25.5K and leaving 12,948 shares worth $640K. The position accounts for 0.17% of the portfolio, ranked #95.

Vectors Research Management first reported a position in IHI in Q3 2020 and has held it in 13 quarters since. The position peaked at $1.24M in Q3 2025. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Vectors Research Management held 12,948 shares of iShares US Medical Devices ETF worth $640K as of Q2 2026.
Vectors Research Management sold 502 iShares US Medical Devices ETF shares in Q2 2026, an estimated $25.5K.
iShares US Medical Devices ETF made up 0.17% of Vectors Research Management's portfolio in Q2 2026, its #95 holding.
Vectors Research Management first reported a position in iShares US Medical Devices ETF in Q3 2020 and has held it in 13 quarters since.
Vectors Research Management's iShares US Medical Devices ETF position peaked at $1.24M in Q3 2025.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Vectors Research Management's 13F filing for Q2 2026, filed 29 Jul 2026.